Literature DB >> 14705838

Scorpion envenomations in young children in central Arizona.

F LoVecchio1, C McBride.   

Abstract

INTRODUCTION: Centruroides sculpturatus, also known as Centruroides exilicauda or bark scorpion, is the only scorpion native to the United States whose venom produces a potentially life-threatening illness, particularly in children.
OBJECTIVES: To describe the distribution of the severity grades following scorpion envenomations, the onset of clinical signs and symptoms, the time to deterioration, and side effects of antivenom treatment in children < or = 2 yrs of age.
METHODS: Prospective case-series with the following inclusion criteria of presumed scorpion envenomation, witnessed scorpion or signs and symptoms consistent with envenomation, patient age < or = 2 yrs, and the call was received by the poison center. After data were entered prospectively, a reviewer who was blinded as to the purpose of the study reviewed the charts. A second reviewer examined 10% of the charts for accuracy in coding. Envenomation severity grades were based on a previously described scorpion grading scale and were correlated with admission rates, clinical deterioration, and outcomes. Descriptive statistics (STATA & EXCEL) were used.
RESULTS: Of the 491 charts, 483 (98%) had adequate information available. The mean age was 20.8 [range 2-24] months with 133 patients (27.5%) presenting to an emergency department (ED), 86 patients (17.8%) received antivenom, and 25 patients (5.2%) were admitted. The p-value for kappa and the 95% confidence interval (CI) for interobserver reliability kappa score was 0.69 with CI (0.44-0.95). The grade distributions were Grade I = 343 cases (71%), Grade II = 8 cases (1.7%), Grade III = 49 cases (10.1%), and Grade IV = 83 cases (17.2%). The mean time to advancement of grade was 14 min (95% CI [10.97,17.06], 99% CI [10.04,18.03]) and the median time was < 1 min (range 0-140 min). Twenty-five patients (5.2%) were admitted, of which 13 were Grade III and 12 were Grade IV. Three patients (0.6% of total), all Grade IV envenomations, were intubated (95% CI [0.0021-0.0181] or an upper limit of 8.7 patients). Antivenom was administered to 86 patients (17.8%). The mean time of abatement of symptoms following antivenom was 31 [95% CI 10-82] min vs. 22.2 h [95% CI 12-46]. There was one acute reaction (rash) to antivenom administration and 49 cases (57%) of serum sickness.
CONCLUSIONS: Clinical progression following scorpion envenomation in children < or = 2 yrs old occurred on average within 14 min of envenomation with onset almost immediately. Serum sickness occurred in 57% of toddlers receiving antivenom and typically lasted less than 3 days. Admissions were less common among patients receiving antivenom.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14705838     DOI: 10.1081/clt-120026514

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  8 in total

1.  Clinical Presentation and Outcomes Associated with Different Treatment Modalities for Pediatric Bark Scorpion Envenomation.

Authors:  Vasanth Coorg; Rachel D Levitan; Richard D Gerkin; Jared Muenzer; Anne-Michelle Ruha
Journal:  J Med Toxicol       Date:  2016-08-03

2.  STATEMENT ON PEDIATRIC TRAVELLERS: Committee to Advise on Tropical Medicine and Travel.

Authors:  S Kuhn; C Hui
Journal:  Can Commun Dis Rep       Date:  2010-06-10

3.  Voltage-gated sodium channel in grasshopper mice defends against bark scorpion toxin.

Authors:  Ashlee H Rowe; Yucheng Xiao; Matthew P Rowe; Theodore R Cummins; Harold H Zakon
Journal:  Science       Date:  2013-10-25       Impact factor: 47.728

4.  Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice.

Authors:  Mitsuteru Akahoshi; Chang Ho Song; Adrian M Piliponsky; Martin Metz; Andrew Guzzetta; Magnus Abrink; Susan M Schlenner; Thorsten B Feyerabend; Hans-Reimer Rodewald; Gunnar Pejler; Mindy Tsai; Stephen J Galli
Journal:  J Clin Invest       Date:  2011-09-19       Impact factor: 14.808

Review 5.  Management of scorpion envenoming: a systematic review and meta-analysis of controlled clinical trials.

Authors:  Chaturaka Rodrigo; Ariaranee Gnanathasan
Journal:  Syst Rev       Date:  2017-04-08

6.  Defensive Venoms: Is Pain Sufficient for Predator Deterrence?

Authors:  Crystal N Niermann; Travis G Tate; Amber L Suto; Rolando Barajas; Hope A White; Olivia D Guswiler; Stephen M Secor; Ashlee H Rowe; Matthew P Rowe
Journal:  Toxins (Basel)       Date:  2020-04-17       Impact factor: 4.546

7.  Arizona bark scorpion venom resistance in the pallid bat, Antrozous pallidus.

Authors:  Bradley H Hopp; Ryan S Arvidson; Michael E Adams; Khaleel A Razak
Journal:  PLoS One       Date:  2017-08-30       Impact factor: 3.240

Review 8.  Benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens.

Authors:  Rashmi Dixit; Jenny Herz; Richard Dalton; Robert Booy
Journal:  Vaccine       Date:  2016-01-20       Impact factor: 3.641

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.